ALMADIYEVA A, IBRAYEV S, TURGAMBAYEVA A, KOSTYUK A, KHISMETOVA Z, AKHMETOVA Z. Cost-effectiveness of Oral Protease Inhibitors Co-administration versus Pegylated Interferon-Α2b and Ribavirin Only for the Patients with Hepatitis C Genotype 1 in Kazakhstan Health Care Settings. Iran J Public Health. 2018;47(12):1845-1853.